A
Aceso Life Science Group Ltd
HKEX:474
Aceso Life Science Group Ltd
HKEX:474
Price:
0.12
HKD
-4.76%
Market Cap:
HK$885.8m
Cash Flow Statement
Cash Flow Statement
Aceso Life Science Group Ltd
Aceso Life Science Group Ltd
Currency: HKD
| Mar-2006 | Sep-2017 | Mar-2018 | Sep-2018 | Mar-2019 | Sep-2019 | Mar-2020 | Sep-2020 | Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||
| Net Income |
31
|
0
|
(526)
|
0
|
(481)
|
0
|
(267)
|
0
|
(323)
|
0
|
(555)
|
0
|
(213)
|
0
|
(823)
|
0
|
(1 027)
|
0
|
|
| Depreciation & Amortization |
2
|
0
|
64
|
0
|
57
|
0
|
57
|
0
|
63
|
0
|
68
|
0
|
52
|
0
|
50
|
0
|
43
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
10
|
14
|
7
|
5
|
3
|
2
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
(9)
|
0
|
470
|
0
|
443
|
0
|
252
|
0
|
402
|
0
|
592
|
0
|
251
|
0
|
824
|
0
|
1 012
|
(17)
|
|
| Cash Taxes Paid |
6
|
0
|
18
|
0
|
8
|
0
|
1
|
0
|
11
|
0
|
3
|
0
|
0
|
0
|
10
|
0
|
5
|
0
|
|
| Cash Interest Paid |
0
|
28
|
61
|
92
|
99
|
116
|
152
|
144
|
114
|
111
|
152
|
175
|
113
|
99
|
142
|
131
|
93
|
71
|
|
| Change in Working Capital |
(4)
|
184
|
(98)
|
(261)
|
(103)
|
(137)
|
(398)
|
(441)
|
37
|
445
|
211
|
330
|
132
|
98
|
(88)
|
(73)
|
(11)
|
132
|
|
| Cash from Operating Activities |
21
N/A
|
184
+787%
|
(90)
N/A
|
(261)
-190%
|
(84)
+68%
|
(137)
-63%
|
(356)
-160%
|
(441)
-24%
|
179
N/A
|
445
+149%
|
316
-29%
|
330
+4%
|
222
-33%
|
98
-56%
|
(37)
N/A
|
(73)
-97%
|
17
N/A
|
115
+576%
|
|
| Investing Cash Flow | |||||||||||||||||||
| Capital Expenditures |
(6)
|
(25)
|
(73)
|
(93)
|
(71)
|
(51)
|
(36)
|
(16)
|
(15)
|
(35)
|
(57)
|
(46)
|
(47)
|
(50)
|
(11)
|
(7)
|
(2)
|
12
|
|
| Other Items |
3
|
(125)
|
(249)
|
(1 367)
|
(1 177)
|
335
|
1 030
|
732
|
15
|
(356)
|
(384)
|
(28)
|
(73)
|
37
|
86
|
386
|
339
|
484
|
|
| Cash from Investing Activities |
(3)
N/A
|
(149)
-5 436%
|
(322)
-115%
|
(1 461)
-354%
|
(1 247)
+15%
|
283
N/A
|
994
+251%
|
716
-28%
|
0
N/A
|
(391)
N/A
|
(441)
-13%
|
(74)
+83%
|
(120)
-62%
|
(13)
+89%
|
75
N/A
|
379
+405%
|
337
-11%
|
496
+47%
|
|
| Financing Cash Flow | |||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
124
|
124
|
0
|
0
|
0
|
168
|
217
|
49
|
(5)
|
(6)
|
(9)
|
(8)
|
0
|
0
|
(13)
|
0
|
|
| Net Issuance of Debt |
(1)
|
(371)
|
260
|
1 536
|
825
|
(271)
|
(307)
|
(127)
|
(479)
|
19
|
294
|
(233)
|
(132)
|
(156)
|
(162)
|
(406)
|
(486)
|
(692)
|
|
| Cash Paid for Dividends |
(20)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
(0)
|
8
|
(29)
|
(48)
|
(1)
|
(64)
|
(214)
|
(207)
|
(113)
|
(80)
|
(163)
|
(79)
|
43
|
(80)
|
279
|
290
|
(88)
|
(70)
|
|
| Cash from Financing Activities |
(21)
N/A
|
(242)
-1 048%
|
355
N/A
|
1 491
+320%
|
824
-45%
|
(335)
N/A
|
(522)
-56%
|
(166)
+68%
|
(375)
-125%
|
(12)
+97%
|
126
N/A
|
(318)
N/A
|
(98)
+69%
|
(244)
-149%
|
117
N/A
|
(116)
N/A
|
(587)
-406%
|
(775)
-32%
|
|
| Change in Cash | |||||||||||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
6
|
22
|
17
|
(7)
|
52
|
(2)
|
(63)
|
12
|
14
|
(4)
|
(30)
|
(12)
|
16
|
8
|
(22)
|
15
|
28
|
|
| Net Change in Cash |
(4)
N/A
|
(203)
-5 687%
|
(35)
+83%
|
(214)
-513%
|
(514)
-140%
|
(137)
+73%
|
115
N/A
|
46
-60%
|
(184)
N/A
|
56
N/A
|
(3)
N/A
|
(92)
-2 967%
|
(8)
+91%
|
(143)
-1 688%
|
163
N/A
|
168
+3%
|
(218)
N/A
|
(136)
+38%
|
|
| Free Cash Flow | |||||||||||||||||||
| Free Cash Flow |
15
N/A
|
159
+973%
|
(163)
N/A
|
(355)
-118%
|
(155)
+56%
|
(188)
-22%
|
(392)
-108%
|
(457)
-16%
|
164
N/A
|
410
+150%
|
259
-37%
|
284
+10%
|
175
-38%
|
48
-73%
|
(48)
N/A
|
(80)
-67%
|
15
N/A
|
127
+747%
|
|
Switch to:
Switch to:
See Also
Discover More
